Increased expression of the NEK7 gene has been reported in patients with gestational diabetes [82], and suppression of NLRP3 inflammasome activation related to NEK7 overexpression has been shown to mitigate diabetes-induced muscle atrophy [83]. The gene discussed is NLRP3; the disease is diabetes mellitus.